- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 243/28 - Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
Patent holdings for IPC class C07C 243/28
Total number of patents in this class: 99
10-year publication summary
|
7
|
7
|
10
|
3
|
8
|
5
|
7
|
3
|
5
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 442 |
12 |
| Gilead Sciences, Inc. | 2134 |
6 |
| Hangzhou DAC Biotech Co., Ltd | 107 |
4 |
| FUJIFILM Corporation | 30010 |
3 |
| Ramot at Tel-Aviv University Ltd. | 1513 |
3 |
| Usher III Initiative, Inc. | 19 |
3 |
| Horitzonts Tecnologics Hungary Korlátolt Felelosségu Társaság | 7 |
3 |
| Sandoz AG | 1394 |
2 |
| Syngenta Crop Protection AG | 6335 |
2 |
| Allergan, Inc. | 2282 |
2 |
| NDSU Research Foundation | 244 |
2 |
| University of Cincinnati | 892 |
2 |
| SWIMC, LLC | 2538 |
2 |
| Genevant Sciences GmbH | 59 |
2 |
| Autobahn Therapeutics, Inc. | 41 |
2 |
| Corteva Agriscience LLC | 2663 |
2 |
| ReNAgade Therapeutics Management Inc. | 50 |
2 |
| F. Hoffmann-La Roche AG | 7893 |
1 |
| Hoffmann-La Roche Inc. | 3602 |
1 |
| 3m Innovative Properties Company | 17614 |
1 |
| Other owners | 42 |